Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
110.67
+3.05 (2.83%)
At close: Jun 27, 2025, 4:00 PM
110.70
+0.03 (0.03%)
After-hours: Jun 27, 2025, 7:41 PM EDT
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
$1,632,670
Profits / Employee
$338,920
Market Cap
137.67B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GILD News
- 1 day ago - Gilead shares rise after US top court ruling on preventative coverage - Reuters
- 3 days ago - Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics - Reuters
- 3 days ago - Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders - Business Wire
- 9 days ago - AHF: Gilead's Greed Kills Promise of Lenacapavir for HIV Prevention - Business Wire
- 9 days ago - Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection - Business Wire
- 9 days ago - FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option - CNBC
- 9 days ago - US FDA approves Gilead's twice-yearly injection for HIV prevention - Reuters
- 10 days ago - Should You Buy Gilead Stock At $110? - Forbes